---
figid: PMC9630094__etat-03-1002101-g001
pmcid: PMC9630094
image_filename: etat-03-1002101-g001.jpg
figure_link: /pmc/articles/PMC9630094/figure/F1/
number: Figure 1
figure_title: ''
caption: 'xCT-based therapeutic strategies. Strategies to target cancer cells with
  high xCT expression. (1) Direct inhibition of xCT; or by targeting xCT-associated
  metabolic vulnerabilities using (2) GLUT inhibitors and (3) glutaminase inhibitors
  (CB-839). PPP: pentose phosphate pathway; α-KG: α-ketoglutarate'
article_title: A xCT role in tumour-associated ferroptosis shed light on novel therapeutic
  options.
citation: Daniela Criscuolo, et al. Explor Target Antitumor Ther. 2022;3(5):570-581.
year: '2022'

doi: 10.37349/etat.2022.00101
journal_title: Exploration of Targeted Anti-tumor Therapy
journal_nlm_ta: Explor Target Antitumor Ther
publisher_name: Open Exploration

keywords:
- Solute carrier family 7 member 11 (SLC7A11)
- reactive oxygen species (ROS) tolerance
- ferroptosis-regulators
- coiled-coil domain containing 6 (CCDC6)
- cancer therapy

---
